En
Non verificato

Enveric Biosciences

Di cosa scriviamo

BiotecnologiaFarmaceuticaPsichiatriaSaluteSanità
21/10/2026
Biotecnologia
Psichiatria
Salute
Medicina - Varie
Industria
Enveric Biosciences Announces Positive Results from Recently Completed IND-enabling ADMET Studies
1.00
01/09/2026
Web e Social Network
Eventi
Biotecnologia
Psichiatria
Salute
Farmaceutica
Enveric Biosciences to Present at H.C. Wainwright 28th Annual Global Investment Conference
1.00
14/08/2026
Mercato azionario
Psichiatria
Salute
Medicina - Varie
Sanità
Farmaceutica
Biotecnologia
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026
1.00
05/08/2026
Industria
Psichiatria
Scienza
Igiene alimentare
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003
1.00
28/07/2026
Economia
Scienza
Igiene alimentare
Biotecnologia
Sanità
Medicina alternativa
Salute
Farmaceutica
Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development
1.00
29/06/2026
Eventi
Fiere
Psichiatria
Salute
Sanità
Farmaceutica
Biotecnologia
Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
1.00
16/06/2026
Eventi
Fiere
Finanza
Biotecnologia
Sanità
Salute
Psichiatria
Enveric Biosciences Announces Participation in 2026 BIO International Convention
1.00
09/06/2026
Eventi
Psichiatria
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Enveric Biosciences to Participate in the UBS 3rd Virtual CNS Day
1.00
02/06/2026
Psichiatria
Salute
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Industria
Enveric Biosciences Initiates Investigational New Drug (IND)-enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0